Nuvalent Financial Statements From 2010 to 2025

NUVL Stock  USD 75.84  0.15  0.20%   
Nuvalent financial statements provide useful quarterly and yearly information to potential Nuvalent investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Nuvalent financial statements helps investors assess Nuvalent's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Nuvalent's valuation are summarized below:
Market Capitalization
5.4 B
Earnings Share
(3.49)
There are over one hundred one available fundamental ratios for Nuvalent, which can be analyzed over time and compared to other ratios. We recommend to check Nuvalent's last-minute fundamental drivers against the all of the trends between 2010 and 2025. The value of Market Cap is estimated to slide to about 841.9 M. The Enterprise Value is projected to slide to about 778 M
Check Nuvalent financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nuvalent's main balance sheet or income statement drivers, such as Depreciation And Amortization of 28.1 M, Interest Expense of 28.1 M or Selling General Administrative of 43.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 5.78. Nuvalent financial statements analysis is a perfect complement when working with Nuvalent Valuation or Volatility modules.
  
Check out the analysis of Nuvalent Correlation against competitors.
For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.

Nuvalent Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets884.4 M842.2 M204.9 M
Slightly volatile
Short and Long Term Debt Total2.4 M2.6 M2.2 M
Slightly volatile
Other Current Liabilities27.2 M25.9 M8.3 M
Slightly volatile
Total Current Liabilities38.4 M36.6 M11.4 M
Slightly volatile
Accounts Payable11.2 M10.7 M3.1 M
Slightly volatile
Cash405 M385.7 M92.3 M
Slightly volatile
Long Term Debt2.4 M2.6 M2.2 M
Slightly volatile
Cash And Short Term Investments869.3 M827.9 M201.1 M
Slightly volatile
Common Stock Shares Outstanding55.6 M67 M50.6 M
Slightly volatile
Liabilities And Stockholders Equity884.4 M842.2 M204.9 M
Slightly volatile
Other Current AssetsM7.6 MM
Slightly volatile
Other Stockholder Equity1.2 B1.1 B268.9 M
Slightly volatile
Total Liabilities27 M36.6 M23.2 M
Slightly volatile
Total Current Assets877.2 M835.5 M203.2 M
Slightly volatile
Short Term DebtM1.8 M2.7 M
Slightly volatile
Common Stock8.5 K8.1 K2.2 K
Slightly volatile
Non Currrent Assets OtherM6.8 M3.8 M
Slightly volatile
Other Assets0.860.92.7 M
Slightly volatile
Net Receivables4.2 M5.1 M3.5 M
Slightly volatile
Common Stock Total EquityK6.9 K5.3 K
Slightly volatile
Capital Surpluse542.9 M717.1 M429.3 M
Slightly volatile

Nuvalent Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative43.8 M41.7 M10.1 M
Slightly volatile
Other Operating Expenses180.5 M171.9 M47.1 M
Slightly volatile
Research Development136.7 M130.2 M37 M
Slightly volatile
Total Operating Expenses180.5 M171.9 M47.1 M
Slightly volatile
Net Interest Income15.1 M26.8 M7.5 M
Slightly volatile
Interest Income15.1 M26.8 M7.5 M
Slightly volatile
Selling And Marketing Expenses29 M32.6 M35.5 M
Slightly volatile

Nuvalent Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation30.9 M29.4 M6.3 M
Slightly volatile
Change In Working Capital13.3 M12.7 M3.3 M
Slightly volatile
Begin Period Cash Flow292 M278.1 M63.8 M
Slightly volatile
Change To Operating Activities3.3 M3.1 M891.6 K
Slightly volatile
Total Cash From Financing Activities208.7 M387.4 M109.1 M
Slightly volatile
End Period Cash Flow405 M385.7 M92.3 M
Slightly volatile
Change To Liabilities11.7 M11.1 M3.3 M
Slightly volatile
Sale Purchase Of Stock330.9 K348.3 K254.9 M
Slightly volatile
Cash And Cash Equivalents Changes127.3 M199.3 M85.7 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Cash Per Share11.6811.133.2178
Slightly volatile
Income Quality0.950.910.8435
Slightly volatile
Current Ratio13.3820.557.7764
Slightly volatile
Graham Number22.8921.87.1202
Slightly volatile
Interest Debt Per Share0.380.360.113
Slightly volatile
Debt To Assets0.470.240.5064
Slightly volatile
Ebt Per Ebit1.060.971.0686
Slightly volatile
Effective Tax Rate0.09820.09350.0259
Slightly volatile
Quick Ratio13.3820.557.7764
Slightly volatile
Net Income Per E B T0.720.810.8797
Slightly volatile
Cash Ratio5.419.493.4338
Slightly volatile
Debt Ratio0.470.240.5064
Slightly volatile

Nuvalent Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap841.9 M1.3 BB
Slightly volatile
Enterprise Value778 M1.1 B947.5 M
Slightly volatile

Nuvalent Fundamental Market Drivers

Cash And Short Term Investments719.9 M

Nuvalent Upcoming Events

21st of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Nuvalent Financial Statements

Nuvalent investors utilize fundamental indicators, such as revenue or net income, to predict how Nuvalent Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-2.3 M-2.4 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Nuvalent is a strong investment it is important to analyze Nuvalent's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nuvalent's future performance. For an informed investment choice regarding Nuvalent Stock, refer to the following important reports:
Check out the analysis of Nuvalent Correlation against competitors.
For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvalent. If investors know Nuvalent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvalent listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.49)
Return On Assets
(0.19)
Return On Equity
(0.30)
The market value of Nuvalent is measured differently than its book value, which is the value of Nuvalent that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvalent's value that differs from its market value or its book value, called intrinsic value, which is Nuvalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvalent's market value can be influenced by many factors that don't directly affect Nuvalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvalent's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvalent is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.